[Anti-CD(25) monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease in 80 patients receiving allogeneic hematopoietic stem cell transplantation].

Tao, T; Xue, S L; Chen, F; Xu, Y; Ma, X; Miao, M; Tang, X W; Wu, D P

Tao, T; Xue, S L; Chen, F; Xu, Y; Ma, X; Miao, M; Tang, X W; Wu, D P.

Affiliation

Tao T; Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Suzhou 215006, China.

Zhonghua Nei Ke Za Zhi ; 57(5): 324-329, 2018 May 01.

Article in Zh | MEDLINE | ID: mdl-29747286

Subject(s)

Antibodies, Monoclonal/therapeutic use; Graft vs Host Disease/drug therapy; Hematopoietic Stem Cell Transplantation/adverse effects; Hematopoietic Stem Cell Transplantation/methods; Salvage Therapy/methods; Antibodies, Monoclonal/administration & dosage; Humans; Incidence; Recurrence; Remission Induction; Risk Factors; Steroids/pharmacology; Survival Rate; Treatment Outcome

Key words

Acute graft vs host disease; Anti-CD(2)5 monoclonal antibody; Hematopoietic stem cell transplantation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Antibodies, Monoclonal Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Nei Ke Za Zhi Year: 2018 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google